Introduction
Rabepar IV is Astemax Biotech’s branded Rabeprazole 20 mg injection, a proton pump inhibitor (PPI) for rapid intravenous acid suppression in acute gastrointestinal conditions.
Key Ingredient
Rabeprazole Sodium 20 mg, when reconstituted, irreversibly blocks the H+/K+ ATPase enzyme in parietal cells, reducing gastric acid production by up to 99% within 1 hour of IV administration.
Health Benefits
It provides fast relief in gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome, and stress-induced gastritis, especially when oral intake is not feasible, preventing complications like bleeding or perforation. IV form achieves higher peak levels than oral, ideal for hospitalized patients.
Recommended Dosage
Administer 20 mg (one vial) IV bolus or infusion once daily for 7-10 days;
